Voyageur Pharmaceuticals (CVE:VM) Shares Down 31.3% – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM) shares dropped 31.3% during mid-day trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during mid-day trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Price Performance

The stock has a market cap of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32. The stock’s 50 day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.